What is the recommended dosing schedule for Voltaren (diclofenac) gel in an adult, including amount per application, frequency, maximum daily dose, treatment duration, and contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Voltaren Gel Dosing

For osteoarthritis pain, apply Voltaren (diclofenac sodium) gel 1% as 4 grams to each affected knee four times daily, using the lowest effective dose for the shortest duration necessary. 1

Standard Dosing Regimen

Amount and Frequency

  • Dose per application: 40 mg diclofenac (2 pump actuations = 4 grams of gel) 1
  • Frequency: Apply twice daily to each painful knee 1
  • Maximum daily dose: 32 grams total per day (16 grams per knee when treating both knees) 1
  • Treatment duration: Use the shortest duration consistent with treatment goals; safety beyond 3 months requires monitoring 2

Application Technique

  • Apply to clean, dry skin only 1
  • Dispense directly onto the knee or into the hand first, then spread evenly around front, back, and sides of the knee 1
  • Prime the pump before first use: Fully depress 4 times and discard this portion 1
  • Wash hands completely after each application 1

Critical Safety Precautions

Immediate Post-Application Care

  • Wait 30 minutes before showering or bathing after application 1
  • Wait until completely dry before covering with clothing or applying sunscreen, insect repellent, cosmetics, or other topical products 1
  • Avoid skin-to-skin contact with others until the treated area is completely dry 1
  • Do not apply external heat or occlusive dressings to treated areas 1

Application Site Restrictions

  • Never apply to: Open wounds, eyes, nose, mouth, or mucous membranes 1
  • Protect treated areas from natural and artificial sunlight 1
  • Use with extreme caution below the knee due to potential healing issues, especially in elderly patients 3

Cardiovascular and Systemic Warnings

Black Box Considerations

  • Diclofenac increases risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal 4
  • Patients with cardiovascular disease or risk factors face elevated risk even with topical formulation 4
  • Topical diclofenac provides 5- to 17-fold lower systemic exposure compared to oral formulations, but systemic absorption still occurs 5

Combination Therapy Restrictions

  • Do not combine with oral NSAIDs unless benefit clearly outweighs risk, and conduct periodic laboratory monitoring if combined 1
  • Elderly patients (≥75 years) should receive topical NSAIDs preferentially over oral formulations due to significantly elevated renal adverse event risk 6
  • Patients with renal insufficiency, heart failure, or cardiovascular disease should avoid combination therapy entirely 6

Special Populations and Contraindications

High-Risk Patients

  • Elderly patients: Topical formulation preferred due to lower systemic exposure and reduced gastrointestinal and renal toxicity 6, 5
  • Renal impairment: Avoid or use with extreme caution; topical formulation reduces but does not eliminate systemic effects 6
  • Cardiovascular disease: Weigh cardiovascular thrombotic risk against pain relief benefit 4

Alternative Indications (Actinic Keratosis)

The 3% diclofenac formulation in hyaluronic acid gel is FDA-approved for actinic keratosis, not osteoarthritis pain:

  • Apply twice daily for 60-90 days 4, 3
  • This is a different formulation and indication than the 1% gel used for joint pain 4

Common Pitfalls to Avoid

  • Dosing errors: The FDA label specifies 2 pump actuations (40 mg) applied 4 times daily, but many sources describe twice-daily dosing—follow the FDA-approved regimen of 4 times daily for optimal efficacy 1
  • Premature clothing coverage: Patients frequently cover treated areas before complete drying, increasing systemic absorption and reducing local efficacy 1
  • Inadequate hand washing: Failure to wash hands after application leads to inadvertent transfer to eyes and mucous membranes 1
  • Combining with oral NSAIDs without monitoring: This substantially increases cardiovascular and renal risks 1
  • Application to lower extremities in elderly: Poor healing sites below the knee require cautious use with potential supervision 3

References

Guideline

Diclofenac Formulations for Actinic Keratosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diclofenac Gel 3% for Actinic Keratosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Safe Use of Nonsteroidal Anti-Inflammatory Drugs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.